RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 69 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,748,000 | +53.2% | 417,942 | -8.2% | 0.00% | 0.0% |
| Q2 2016 | $2,446,000 | +19.9% | 455,391 | +2.7% | 0.00% | 0.0% |
| Q1 2016 | $2,040,000 | -6.0% | 443,554 | +6.3% | 0.00% | 0.0% |
| Q4 2015 | $2,171,000 | -10.7% | 417,298 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $2,432,000 | -66.6% | 402,043 | -12.9% | 0.00% | -50.0% |
| Q2 2015 | $7,291,000 | +76.7% | 461,750 | +21.6% | 0.00% | +100.0% |
| Q1 2015 | $4,127,000 | +6.8% | 379,676 | +3.4% | 0.00% | 0.0% |
| Q4 2014 | $3,864,000 | +10.6% | 367,300 | +0.8% | 0.00% | 0.0% |
| Q3 2014 | $3,495,000 | -54.5% | 364,519 | -45.1% | 0.00% | 0.0% |
| Q2 2014 | $7,676,000 | +134.3% | 664,546 | +102.8% | 0.00% | 0.0% |
| Q1 2014 | $3,276,000 | -23.5% | 327,623 | -0.4% | 0.00% | 0.0% |
| Q4 2013 | $4,284,000 | -60.8% | 328,978 | -55.1% | 0.00% | -50.0% |
| Q3 2013 | $10,924,000 | +251.4% | 732,088 | +120.2% | 0.00% | +100.0% |
| Q2 2013 | $3,109,000 | – | 332,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
| Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
| WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
| Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
| FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
| Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
| Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |